4D Molecular Therapeutics Inc 4D-150 Phase 1/2 PRISM Interim Clinical Data - Corporate Call Transcript - Thomson StreetEvents

4D Molecular Therapeutics Inc 4D-150 Phase 1/2 PRISM Interim Clinical Data - Corporate Call Transcript

4D Molecular Therapeutics Inc 4D-150 Phase 1/2 PRISM Interim Clinical Data - Corporate Call Transcript - Thomson StreetEvents
4D Molecular Therapeutics Inc 4D-150 Phase 1/2 PRISM Interim Clinical Data - Corporate Call Transcript
Published Apr 27, 2023
Published Apr 27, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of FDMT.OQ conference call or presentation 27-Apr-23 12:00pm GMT

  
Report Type:

Transcript

Source:
Company:
4D Molecular Therapeutics Inc
Ticker
FDMT.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

4D Molecular Therapeutics Inc at Chardan Genetic Medicines Conference Transcript – 2023-10-02 – US$ 54.00 – Edited Transcript of FDMT.OQ presentation 2-Oct-23 6:30pm GMT

4D Molecular Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript – 2023-06-12 – US$ 54.00 – Edited Transcript of FDMT.OQ presentation 12-Jun-23 9:00pm GMT

4D Molecular Therapeutics Inc at Jefferies Healthcare Conference Transcript – 2023-06-09 – US$ 54.00 – Edited Transcript of FDMT.OQ presentation 9-Jun-23 2:00pm GMT

4D Molecular Therapeutics Inc 4D-710 Phase 1/2 AEROW Interim Clinical Data Call Transcript – 2023-06-07 – US$ 54.00 – Edited Transcript of FDMT.OQ conference call or presentation 7-Jun-23 8:30pm GMT

4D Molecular Therapeutics Inc at Bank of America Global Healthcare Conference Transcript – 2023-05-09 – US$ 54.00 – Edited Transcript of FDMT.OQ presentation 9-May-23 11:20pm GMT

4D Molecular Therapeutics Inc 4D-310 Phase 1/2 Interim Clinical Data Call Transcript – 2023-02-22 – US$ 54.00 – Edited Transcript of FDMT.OQ conference call or presentation 22-Feb-23 9:30pm GMT

4D Molecular Therapeutics Inc Phase 1/2 Clinical Trial of 4D-150 for Wet AMD - Corporate Call Transcript – 2022-11-14 – US$ 54.00 – Edited Transcript of FDMT.OQ conference call or presentation 14-Nov-22 1:00pm GMT

4D Molecular Therapeutics Inc Interim Clinical Data Presented at NACFC - Corporate Call Transcript – 2022-11-03 – US$ 54.00 – Edited Transcript of FDMT.OQ conference call or presentation 3-Nov-22 8:30pm GMT

4D Molecular Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript – 2022-06-15 – US$ 54.00 – Edited Transcript of FDMT.OQ presentation 15-Jun-22 3:40pm GMT

4D Molecular Therapeutics Inc at Bank of America Healthcare Conference Transcript – 2022-05-10 – US$ 54.00 – Edited Transcript of FDMT.OQ presentation 10-May-22 3:40pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "4D Molecular Therapeutics Inc 4D-150 Phase 1/2 PRISM Interim Clinical Data - Corporate Call Transcript" Apr 27, 2023. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/4D-Molecular-Therapeutics-Inc-4D-150-Phase-1-2-PRISM-Interim-Clinical-Data-Corporate-Call-T15548063>
  
APA:
Thomson StreetEvents. (2023). 4D Molecular Therapeutics Inc 4D-150 Phase 1/2 PRISM Interim Clinical Data - Corporate Call Transcript Apr 27, 2023. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/4D-Molecular-Therapeutics-Inc-4D-150-Phase-1-2-PRISM-Interim-Clinical-Data-Corporate-Call-T15548063>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.